Pyrifazimine

吡法齐明

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NamePyrifazimine
Drug Alias Name氯法齐明前药TBI-166
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA inhibitors
TargetsDNA
Therapy Area/IndicationsTuberculosis, PulmonaryExtensively Drug-Resistant TuberculosisTuberculosis, Multidrug-Resistant +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesBeijing Union Pharmaceutical FactoryInstitue Of Materia Medica Chinese Academy Of Medical Science
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesBeijing Xiehe No 2 Pharmaceutical FactoryInstitue Of Materia Medica Chinese Academy Of Medical Science
Inactive CompaniesN/A
Active IndicationsTuberculosis, PulmonaryExtensively Drug-Resistant TuberculosisTuberculosis
Inactive IndicationsTuberculosis, Multidrug-Resistant

Other Information

ATC CodeN/A
Related LinksN/A